Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing Pharmacogenetics in the Busulfan Dosing Method for Children Undergoing Hematopoietic Stem-cell Transplantation: a Prospective, Multicentric, Randomized Clinical Trial

NCT04822532 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT04822532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04822532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing Pharmacogenetics in the Busulfan Dosing Method for Children Undergoing Hematopoietic Stem-cell Transplantation: a Prospective, Multicentric, Randomized Clinical Trial
Lead sponsor
University Hospital, Geneva
Phase
Not applicable
Overall status
Unknown status
Start date
June 15, 2021
Completion date
June 30, 2025
Enrollment
260 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allogeneic hematopoietic stem cell transplantation, autologous hematopoietic stem cell transplantation, hematopoietic stem cell transplantation